Archives

by in
Entry Author Date Location
21 Red Flags to Watch for in a Biotech Company 10/21/13 National
PSivida, Alimera Shares Fall as FDA Rejects Eye Drug for Third Time 10/18/13 Boston
East Coast Biotech Roundup: Schenkein, PureTech/JDRF, Sage, & More 10/18/13 Boston
David Schenkein, Cancer Doc Turned CEO, Aims to Build New Genentech 10/16/13 Boston
The $100M Club: Where the Major League Life Sciences Companies Are 10/14/13 National
NJ’s Pain is NY’s Gain as Roche Christens Manhattan Collaboration Hub 10/01/13 New York
Sutro Aims to Deliver Anti-Tumor “Warheads” More Precisely 10/01/13 San Francisco
Ophthotech Prices IPO at $22 Per Share, Reels in $167M 09/24/13 New York
The Best Biotech Graduate Schools in Real Life 09/23/13 National
10 Ways to Live Longer, Without Help from Google 09/20/13 National
Genentech Aims to Set Precedent With FDA OK in Early Breast Cancer 09/11/13 San Francisco
5 Things Biotechs Should Do to Take Advantage of The Boom 09/05/13 New York
Syndax Pockets $26.6M For Final Stage Push With Cancer Drug 08/27/13 Boston
Why Good Drugs Sometimes Fail: The Bexxar Story 08/26/13 National
Ophthotech Eyes $85M IPO With Late-Stage Clinical Trial in Sight 08/15/13 New York
Six Reasons Why Giving Scientists Big Bonuses Won’t Fix Pharma R&D 08/12/13 National
Ensemble Reels in Novartis to Develop Oral, Mid-Sized Inflammation Drugs 08/06/13 Boston
A Band of Postdocs Pursues a New York Biotech Dream in Harlem 08/05/13 New York
Agios Prices Upsized IPO Above Range, Preps For Nasdaq Debut 07/24/13 Boston
SMC Bio Looks to Heal Bones With Carbohydrates, Not Stem Cells 07/18/13 San Francisco
Why I Won’t Cheer If Onyx Pharma Is Sold for Megabucks 07/15/13 National
Forma, CRT Deal Part of Broader Research Initiative 07/09/13 Boston
Baseball and Biopharma: More Alike Than You Might Realize 07/03/13 Seattle
Q2 Review: Top San Francisco Stories from April, May, and June 07/01/13 San Francisco
Bayer Joins with Seattle Genetics in Antibody-Drug Conjugate Deal 06/25/13 Seattle
Immune Design, NY Non-Profits Team Up to Boost Cancer Drugs 06/12/13 Seattle
Agios Files For IPO With Plans to Raise $86M 06/11/13 Boston
Profiles in Long-Termism: Sarepta Therapeutics CEO Chris Garabedian 06/10/13 National
CytomX Snags $25M From Pfizer to Make Souped-Up Antibodies 06/06/13 San Francisco
ASCO Wrap-Up: Cancer News from the West Coast 06/04/13 National
Page 2 of 15 « previous page · next page »